These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 9499049)
1. Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication. Poon B; Chen IS J Virol; 1998 Mar; 72(3):1959-66. PubMed ID: 9499049 [TBL] [Abstract][Full Text] [Related]
2. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion. Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634 [TBL] [Abstract][Full Text] [Related]
3. Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2. Rosenberg AR; Delamarre L; Preira A; Dokhélar MC J Virol; 1998 Sep; 72(9):7609-14. PubMed ID: 9696862 [TBL] [Abstract][Full Text] [Related]
4. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin. Jassal SR; Pöhler RG; Brighty DW J Virol; 2001 Sep; 75(17):8317-28. PubMed ID: 11483777 [TBL] [Abstract][Full Text] [Related]
5. Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells. Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y J Virol; 1997 Jan; 71(1):601-7. PubMed ID: 8985389 [TBL] [Abstract][Full Text] [Related]
6. Syncytium formation by recombinant HTLV-II envelope glycoprotein. Li QX; Camerini D; Xie Y; Greenwald M; Kuritzkes DR; Chen IS Virology; 1996 Apr; 218(1):279-84. PubMed ID: 8615036 [TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type 1 envelope-mediated syncytium formation can be activated in resistant Mammalian cell lines by a carboxy-terminal truncation of the envelope cytoplasmic domain. Kim FJ; Manel N; Boublik Y; Battini JL; Sitbon M J Virol; 2003 Jan; 77(2):963-9. PubMed ID: 12502812 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms affecting HTLV type 1-dependent fusion at the cell membrane: implications for inhibiting viral transmission. Daenke S; Booth S AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1731-6. PubMed ID: 11080818 [TBL] [Abstract][Full Text] [Related]
9. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins. Berlioz-Torrent C; Shacklett BL; Erdtmann L; Delamarre L; Bouchaert I; Sonigo P; Dokhelar MC; Benarous R J Virol; 1999 Feb; 73(2):1350-61. PubMed ID: 9882340 [TBL] [Abstract][Full Text] [Related]
10. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains. Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053 [TBL] [Abstract][Full Text] [Related]
11. Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection. Agadjanyan MG; Ugen KE; Wang B; Williams WV; Weiner DB J Virol; 1994 Jan; 68(1):485-93. PubMed ID: 8254759 [TBL] [Abstract][Full Text] [Related]
12. Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism. Kannian P; Fernandez S; Jones KS; Green PL J Virol; 2013 Aug; 87(16):9344-52. PubMed ID: 23785214 [TBL] [Abstract][Full Text] [Related]
13. HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding. Daenke S; Booth S J Cell Sci; 2000 Jan; 113 ( Pt 1)():37-44. PubMed ID: 10591623 [TBL] [Abstract][Full Text] [Related]
14. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies. Tallet B; Astier-Gin T; Moynet D; Londos-Gagliardi D; Guillemain B AIDS Res Hum Retroviruses; 2001 Mar; 17(4):337-48. PubMed ID: 11242520 [TBL] [Abstract][Full Text] [Related]
15. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission. Pique C; Lagaudrière-Gesbert C; Delamarre L; Rosenberg AR; Conjeaud H; Dokhélar MC Virology; 2000 Oct; 276(2):455-65. PubMed ID: 11040136 [TBL] [Abstract][Full Text] [Related]
16. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290 [TBL] [Abstract][Full Text] [Related]
17. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia. Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424 [TBL] [Abstract][Full Text] [Related]